Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Everything that you are ever going to want to know about running shoes: Running Shoes Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
  2. Have you considered the Critical Thinking and Skeptical Boot Camp, for taking it to the next level? See here for more.
    Dismiss Notice
  3. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Acellular dermal regenerative tissue matrix for diabetic foot ulcers

Discussion in 'Diabetic Foot & Wound Management' started by NewsBot, Aug 6, 2008.

  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds.
    Winters CL, Brigido SA, Liden BA, Simmons M, Hartman JF, Wright ML.
    Adv Skin Wound Care. 2008 Aug;21(8):375-81
     
  2. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Acellular Fetal Bovine Dermal Matrix for Treatment of Chronic Ulcerations of the Midfoot Associated With Charcot Neuroarthropathy
    Steven J. Kavros
    Foot Ankle Spec June 19, 2012
     
  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The Use of PriMatrix, a Fetal Bovine Acellular Dermal Matrix, in Healing Chronic Diabetic Foot Ulcers: A Prospective Multicenter Study.
    Kavros SJ, Dutra T, Gonzalez-Cruz R, Liden B, Marcus B, McGuire J, Nazario-Guirau L.
    Adv Skin Wound Care. 2014 Aug;27(8):
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    This clinical trial was just registered:
    PriMatrix for the Management of Diabetic Foot Ulcers
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis.
    Guo X et al
    Int J Surg. 2017 Feb 14;40:1-7. doi: 10.1016/j.ijsu.2017.02.008.
     
  6. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The Role of Dermal Matrices in Treating Inflammatory and Diabetic Wounds.
    Climov M et al
    Plast Reconstr Surg. 2016 Sep;138(3 Suppl):148S-57S.
     
  7. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    A Randomized Clinical Trial of a Human Acellular Dermal Matrix Demonstrated Superior Healing Rates for Chronic Diabetic Foot Ulcers over Conventional Care and an Active Acellular Dermal Matrix Comparator.
    Cazzell S et al
    Wound Repair Regen. 2017 May 24. doi: 10.1111/wrr.12551.
     
  8. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Failure rates of artificial dermis products in treatment of diabetic foot ulcer: A systematic review and network meta-analysis.
    Tchero H et al
    Wound Repair Regen. 2017 Jun 8. doi: 10.1111/wrr.12554
     
  9. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.
    Kraus I, Sabolinski ML, Skornicki M, Parsons NB.
    Wounds. 2017 May;29(5):125-132.
     
  10. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Cellular versus Acellular Matrix Devices in the Treatment of Diabetic Foot Ulcers: Interim Results of a Comparative Efficacy Randomized Controlled Trial.
    Tchanque-Fossuo CN et al
    J Tissue Eng Regen Med. 2019 May 9
     
  11. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Clinical Efficacy of Acellular Dermal Matrix Paste in Treating Diabetic Foot Ulcers.
    Lee M et al
    Wounds. 2019 Dec 9
     
  12. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The Efficacy and Safety of Acellular Matrix Therapy for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Clinical Trials.
    Huang W et al
    J Diabetes Res. 2020 Feb 1
     
Loading...

Share This Page